Integer Holdings Corp (ITGR) Stock
4 of the hedge funds AlphaScala tracks reported ITGR in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $90.25M. Company insiders reported 0 open-market buys and 3 sales on SEC Form 4 in the 90 days to Oct 21, 2026.
Which hedge funds own ITGR?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 966K | $90.25M | +39% |
| Millennium Management Israel Englander | 365K | $34.14M | -22% |
| D.E. Shaw David Shaw | 32K | $2.96M | -78% |
| Blackstone | 3K | $274.7K | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Integer Holdings Corp insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Sep 15, 26 | Thor Kirk K | Chief Human Resources Officer | SELL | 11.8K | $1.5M |
| Sep 14, 26 | Thor Kirk K | Chief Human Resources Officer | SELL | 19.8K | $2.5M |
| Sep 8, 26 | Senn Andrew | President, Growth & Innovation | SELL | 9.4K | $1.2M |
SEC Form 4 filings as of Oct 21, 2026
See cluster-buy signals across all tickers →ITGR price chart
Powered by TradingViewWhat does Integer Holdings Corp do?
Integer Holdings Corporation is a leading provider of advanced medical device solutions, recognized as a major player within the global healthcare sector. Specializing in the design, development, and manufacturing of complex medical devices and components, Integer Holdings serves a wide array of markets, including cardiovascular, neuromodulation, orthopedic, and portable medical technology. The company is known for supplying sophisticated products such as cardiac rhythm management devices, neurostimulation systems, vascular and implantable components, as well as batteries supporting critical medical and healthcare equipment. Integer Holdings occupies an important position as a partner to medical device original equipment manufacturers (OEMs), supporting innovation and scaling in both established and emerging medical technology markets. With a substantial market capitalization and diversified revenue streams, Integer Holdings demonstrates strong financial fundamentals and resilience in the competitive healthcare and medical device manufacturing industry. Its expertise and comprehensive service offerings position it as a crucial link in the value chain, helping to advance patient care through next-generation technology and rigorous quality standards.